Seaford Pharmaceuticals Named CSHP’s Industry Corporate Supporter for 2023-2024
We are delighted to announce that Seaford Pharmaceuticals has been honoured with the esteemed title of Industry Corporate Supporter by the Canadian Society of Hospital Pharmacists (CSHP) for 2023-2024.
This recognition is a testament to Seaford’s unwavering commitment to excellence in the pharmaceutical industry and our dedication to supporting the objectives of professional societies like CSHP.
The Industry Corporate Supporter status is specially crafted for pharmaceutical companies that align with and actively contribute to the goals of the Society. Seaford Pharmaceuticals is proud to be counted among the select companies that share this commitment to advancing healthcare and pharmacy practice. This esteemed status reflects the collective dedication and hard work of each member of the Seaford team.
We are excited about the opportunities that lie ahead and the positive impact we can make in collaboration with CSHP. This recognition not only enhances Seaford’s standing in the pharmaceutical industry but also opens new avenues for networking and collaboration within the healthcare community.
To learn more about our Industry Corporate Supporter status and to view CSHP’s official announcement, please visit https://www.cshp.ca/Site/Member-Centre/Industry-Supporter/Site/Content/Member-Centre/industry-corporate-supporter.aspx?hkey=150e58fb-12cf-4fec-953d-a9e6f2612ed5.
Seaford Pharmaceuticals expresses heartfelt gratitude to the entire team for their ongoing dedication and valuable contributions to our collective success. We look forward to a successful and impactful year ahead, furthering our commitment to excellence and innovation in pharmaceuticals.
For further information and updates, stay tuned to our Press Section.